Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Quiroga, B; Galan, I; de Vinuesa, SG; Goicoechea, M; Verdalles, U; Luno, J.

Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease

NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015; 30(5): 801-806 Nº de citas: 22 [doi:10.1093/ndt/gfv059]

Goicoechea, M; de Vinuesa, SG; Verdalles, U; Verde, E; Macias, N; Santos, A; de Jose, AP; Cedeno, S; Linares, T; Luno, J.

Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial

AMERICAN JOURNAL OF KIDNEY DISEASES. 2015; 65(4): 543-549 Nº de citas: 241 [doi:10.1053/j.ajkd.2014.11.016]

Caro, J; Gutierrez-Solis, E; Rojas-Rivera, J; Agraz, I; Ramos, N; Rabasco, C; Espinosa, M; Valera, A; Martin, M; Frutos, MA; Perea, L; Juarez, GF; Ocana, J; Arroyo, D; Goicoechea, M; Fernandez, L; Oliet, A; Hernandez, Y; Romera, A; Segarra, A; Praga, M.

Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015; 30(3): 467-474 Nº de citas: 55 [doi:10.1093/ndt/gfu306]

Perez, JP; Lafuente, O; Sanchez-Sobrino, B; Saez, MJP; Garcia, AF; Llamas, F; Lopez-Sanchez, P; Rodriguez-Ferrero, ML; Zarraga, S; Ramos, A; Pascual, J.

Kidney Transplantation With Organs From Donors After Circulatory Death Type 3: A Prospective Multicentric Spanish Study (GEODAS 3)

TRANSPLANTATION PROCEEDINGS. 2015; 47(1): 27-29 Nº de citas: 4 [doi:10.1016/j.transproceed.2014.12.008]

Arroyo, D; Panizo, N; Abad, S; Vega, A; Rincon, A; de Jose, AP; Lopez-Gomez, JM.

INTRAPERITONEAL FLUID OVERESTIMATES HYDRATION STATUS ASSESSMENT BY BIOIMPEDANCE SPECTROSCOPY

PERITONEAL DIALYSIS INTERNATIONAL. 2015; 35(1): 85-89 Nº de citas: 19 [doi:10.3747/pdi.2013.00187]

Yuste, C; Quiroga, B; de Vinuesa, SG; Goicoechea, MA; Barraca, D; Verdalles, U; Luno, J.

The effect of some medications given to CKD patients on vitamin D levels

NEFROLOGIA. 2015; 35(2): 150-156 Nº de citas: 6

Humanes, B; Jado, JC; Camano, S; Lopez-Parra, V; Torres, AM; Alvarez-Sala, LA; Cercenado, E; Tejedor, A; Lazaro, A.

Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity

Biomed Research International. 2015; 2015: Nº de citas: 54 [doi:10.1155/2015/704382]

Gonzalez-Del Vecchio, M; Vena, A; Valerio, M; Marin, M; Verde, E; Munoz, P; Bouza, E.

Coxiella burnetii Infection in Hemodialysis and Other Vascular Grafts

MEDICINE. 2014; 93(24): 364-371 Nº de citas: 8 [doi:10.1097/MD.0000000000000218]

Vega, A; Ruiz, C; Abad, S; Quiroga, B; Velazquez, K; Yuste, C; Aragoncillo, I; Gomez, JML.

Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis

RENAL FAILURE. 2014; 36(7): 1073-1077 Nº de citas: 17 [doi:10.3109/0886022X.2014.917937]

Vega, A; de Vinuesa, SG; Goicoechea, M; Verdalles, U; Martinez-Pueyo, ML; Chacon, A; Quiroga, B; Luno, J.

Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease

INTERNATIONAL UROLOGY AND NEPHROLOGY. 2014; 46(6): 1161-1167 Nº de citas: 12 [doi:10.1007/s11255-013-0607-8]

Bouza, E; Rojas, L; Guembe, M; Marin, M; Anaya, F; Luno, J; Lopez, JM; Munoz, P.

Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2014; 78(3): 316-319 Nº de citas: 22 [doi:10.1016/j.diagmicrobio.2013.12.008]

de Jose, AP; Verdalles-Guzman, U; Abad, S; Vega, A; Reque, J; Panizo, N; Rincon, A; Yuste, C; Arroyo, D; Lopez-Gomez, JM.

Metabolic syndrome is associated with cardiovascular events in haemodialysis

NEFROLOGIA. 2014; 34(1): 69-75 Nº de citas: 13 [doi:10.3265/Nefrologia.pre2013.Oct.12092]

Arroyo, D; Panizo, N; Abad, S; Vega, A; Perez-de Jose, A; Lopez-Gomez, JM.

The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients

NEFROLOGIA. 2014; 34(2): 199-204 Nº de citas: 2 [doi:10.3265/Nefrologia.pre2013.Nov.12145]

Quiroga, B; Villaverde, M; Vega, A; Abad, S; Reque, J; Lopez-Gomez, JM.

Procalcitonin as an early predictor of acute infection in hemodialysis patients

NEFROLOGIA. 2014; 34(3): 341-346 Nº de citas: 9 [doi:10.3265/Nefrologia.pre2014.Mar.12313]

Gorostidi, M; Santamaria, R; Alcazar, R; Fernandez-Fresnedo, G; Galceran, JM; Goicoechea, M; Oliveras, A; Portoles, J; Rubio, E; Segura, J; Aranda, P; de Francisco, ALM; del Pino, MD; Fernandez-Vega, F; Gorriz, JL; Luno, J; Marin, R; Martinez, I; Martinez-Castelao, A; Orte, LM; Quereda, C; Rodriguez-Perez, JC; Rodriguez, M; Ruilope, LM.

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease

NEFROLOGIA. 2014; 34(3): 302-316 Nº de citas: 45 [doi:10.3265/Nefrologia.pre2014.Feb.12464]

Runkle, I; Villabona, C; Navarro, A; Pose, A; Formiga, F; Tejedor, A; Poch, E.

Treatment of hyponatremia induced by the syndrome of inappropriate antidiuretic hormone secretion: a multidisciplinary algorithm

NEFROLOGIA. 2014; 34(4): 439-450 Nº de citas: 20 [doi:10.3265/Nefrologia.pre2014.Apr.12220]

Vega, A; Quiroga, B; Abad, S; Ruiz, C; Lopez-Gomez, JM.

Study on overhydration in dialysis patients and its association with inflammation

NEFROLOGIA. 2014; 34(5): 579-583 Nº de citas: 19 [doi:10.3265/Nefrologia.pre2014.Jun.12422]

Vega, A; Abad, S; Verdalles, U; Aragoncillo, I; Velazquez, K; Quiroga, B; Escudero, V; Lopez-Gomez, JM.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

Hippokratia. 2014; 18(4): 315-318 Nº de citas: 14